Vor Biopharma Inc. filed a report on December 15, 2025, announcing a private placement of 13,876,032 shares at $10.81 each, raising approximately $150 million for clinical development and corporate purposes. This event is significant from an equity investor perspective and is categorized under 'Changes in capital structure'.